Refine the list (min. 2 characters)
Keynote Presentation (In-Person)
A new and upgraded approach to the diseased states and wellness, and to re-shape tomorrow’s healthcare whilst doing it today, resulted in a new global trend in the healthcare services, namely, Personalized and Precision Medicine (PPM). PPM as a Unique Entity demonstrating a [....] » Read More
Oral Presentation (In-Person)
Biodesigners, biotechnologists and biomanufacturers are beginning to realize the promise of personalized and precision medicine (PPM), translating to direct benefit to patients or persons-at-risk. Both PPM, personalized vaccinomics and nanobiotechnologies are being integrated int [....] » Read More
Oral Presentation (In-Person)
Title: One health approaches to echinococcosis control: The role of vaccines
Background: Echinococcosis (hydatid disease) is a neglected zoonosis caused by Echinococcus granulosus and Echinococcus multilocularis, affecting over one million people globally and causing annual economic losses of approximately $3 billion. The disease cycle involves definitive [....] » Read More
Keynote Presentation (In-Person)
The unprecedented rise in global population has intensified the need for safe, effective, and reversible contraceptive strategies to mitigate the far-reaching consequences of overpopulation. In recent decades, immunocontraception has emerged as a promising and biologica [....] » Read More
Oral Presentation (In-Person)
Title: Viral proteins activating PKA as an antiviral vaccine target
Viral infections like HIV and Ebola have created a link to the intracellular stress system via the cAMP-PKA pathway. This allows the virus to suppress T-helper cell activation and interferon signaling, while simultaneously using PKA to boost its replication in the case of Ebola i [....] » Read More
Oral Presentation (In-Person)
Chronic lymphocytic leukemia (CLL) progression is associated with profound immune dysfunction and a marked reduction of miR-181b-5p (miR-181b), a microRNA involved in leukemic cell apoptosis and immune regulation. Here, we investigated whether restoration of miR-181b may improve [....] » Read More
Oral Presentation (In-Person)
Background: Climate change poses an increasing threat to healthcare systems, particularly vaccine cold chain management in low- and middle-income countries. Rising temperatures, erratic weather patterns, power interruptions, and extreme climatic events can compromise vaccine [....] » Read More
Poster Presentation (In-Person)
Title: Enzyme-free electrochemical strategy for mRNA vaccine detection
Tumor mRNA vaccines have demonstrated increasing potential in immunotherapy. With the advancement of vaccine development, monitoring in vivo levels and pharmacokinetic profiles is becoming essential. However, existing detection techniques often require large sample volumes and fa [....] » Read More
Poster Presentation (In-Person)
Title: How does COVID-19 disrupt immune homeostasis and its association with multiple system diseases?
Background: The immunopathological events and immune residues induced by COVID-19, particularly lymphocyte damage, play a central role in the pathogenesis of Long COVID. Identifying easy-to-detect biomarkers is crucial for understanding the persistence of symptoms. Objective: [....] » Read More
Poster Presentation (In-Person)
Influenza is a highly contagious respiratory illness caused by influenza viruses, which remains a persistent challenge on global health. Vaccination is the most effective intervention to mitigate the public health burden caused by pandemic or endemic influenza. Compared to conven [....] » Read More
Poster Presentation (In-Person)
Background: Infectious bronchitis virus (IBV) remains one of the most challenging pathogens affecting poultry health worldwide, particularly in regions where multiple genotypes co-circulate. In Egypt, the emergence and persistence of Variant 2–like strains (GI-23 lineage) a [....] » Read More
Keynote Presentation (Virtual)
Title: Classical examples of the concept of the ASIA syndrome; CPI, SBI and vaccines
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) was first introduced in 2011 by Shoenfeld et al. and encompasses a cluster of related immune mediated diseases, which develop among genetically prone individuals as a result of adjuvant agent exposure. Since the recogni [....] » Read More
Keynote Presentation (Virtual)
For meeting the financial, quality and safety challenges as well as expectations of the patients, health and social care systems around the globe currently undergo a transformation towards personalized, preventive, predictive, participative precision medicine (5PM), supported by [....] » Read More
Oral Presentation (Virtual)
Background: The widespread implementation of heterologous COVID-19 vaccination strategies has substantially improved vaccine-induced protection against SARS-CoV-2. However, concerns regarding the potential induction of autoantibodies associated with autoimmune diseases and cancer [....] » Read More
Oral Presentation (Virtual)
Title: Autoimmunity after COVID-19: Mechanism, clinical evidence and emerging directions
Background: Since the emergence of SARS-CoV-2, increasing evidence has linked COVID-19 to the development of autoimmune phenomena ranging from transient autoantibody production to chronic, clinically significant autoimmune disease. Proposed mechanisms include molecular mimicry, b [....] » Read More
Oral Presentation (Virtual)
Title: Immune Memory based Classification of Human Herd [IMCHH]
Individual and population/herd immunity are at most depend on the nature of effector cells on first encounter and immune memory cells on re-infection or boost vaccination. The present opinion paper tempts to propose human herd classification on the bases of memory immune ce [....] » Read More
Oral Presentation (Virtual)
Title: Vaccine acceptance and health seeking behaviour the way forward
Vaccines are biological agents which provide active acquired immunity against infectious diseases. Agents in vaccines have similar properties with the micro-organism which causes the disease. Benefits of vaccination cannot be over emphasized as it is most cost-effective strategy [....] » Read More
Oral Presentation (Virtual)
Title: Modular protein nanorings for next-generation immunoengineering
Immune interventions remain constrained by limited nanoscale control over how antigens and immune signals are presented, creating an immunoengineering bottleneck that impacts both communicable diseases (e.g., rapidly evolving influenza) and non-communicable diseases (e.g., Parkin [....] » Read More
Oral Presentation (Virtual)
Title: Subunit nasal vaccines: Overcoming barriers to innovation
Introduction: The development of mucosal vaccines has historically been limited by the lack of suitable adjuvants and concerns about potential neurotoxic effects. Prior to COVID-19, only one mucosal vaccine was commercially available. The accelerated technological progress and re [....] » Read More
© 2026 Mathews International LLC. All rights reserved.
